Enfermedades infecciosas y vacunas
INFORMACIÓN DE CONTACTO
Grupo de Investigación
CASTILLA CATALAN, JESUS
GARCIA CENOZ, MANUEL
MARTINEZ BAZ, IVAN
Lucaccioni, H, Pozo, F, Pérez-Gimeno, G, Dürrwald, R, Uras, M, Domegan, L, Oroszi, B, Meijer, A, Trobajo-Sanmartín, C, Ujvari, D, Rodrigues, AP, Mlinaric, I, Lazar, M, Wagner, ER, Erdwiens, A, Enouf, V, Mckenna, A, Túri, G, De Lange, M, Martínez-Baz, I, Latorre-Margalef, N, Guiomar, R, Filipovic, SK, Dinu, S, Mokoroa, O, Tolksdorf, K, Masse, S, Bennett, C, Kristóf, K, Hooiveld, M, Castilla, J, Santos, J, Vucina, VV, Popescu, R, Bacci, S, Kaczmarek, M, Kissling, E
"Vaccine effectiveness against medically attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25".
Expert Rev. Vaccines. 25(1): 2645378. 2026. [doi:10.1080/14760584.2026.2645378]
Delaunay, CL, Nunes, B, Monge, S, De Lange, M, Túri, G, Machado, A, Latorre-Margalef, N, Mlinaric, I, Lazar, M, Rocamora, PB, Erdwiens, A, Sève, N, Domegan, L, Martínez-Baz, I, Hooiveld, M, Oroszi, B, Guiomar, R, Sperk, M, Filipovic, SK, Pascu, C, Dopido, JAL, Dürrwald, R, Rameix-Welti, MA, Mckenna, A, Castilla, J, Van Hagen, C, Knol, M, Kaczmarek, M, Kissling, E
"Identification of the causal odds ratio in test-negative-design studies of COVID-19 vaccine effectiveness".
Int. J. Epidemiol.. 55(2): dyag039. 2026. [doi:10.1093/ije/dyag039]
Kissling E, Nunes B, Hooiveld M, Martínez-Baz I, Monge S, Robertson C, Knol M, Sève N, Mlinaric I, Domegan L, Machado A, Whitaker H, Lazar M, Meijer A, Enkirch T, Casado I, Pérez-Gimeno G, William N, Enouf V, Filipovic SK, McKenna A, Rodrigues AP, de Lusignan S, Timnea OC, Latorre-Margalef N, Castilla J, Pozo F, Hamilton M, Masse S, Ilic M, Basile L, O'Donnell J, Guiomar R, Riess M, Popescu RM, Rose AMC, Andrews N, Bacci S, Celentano LP, Valenciano M, Moren A, Beutels P, Hens N, Ecdc Primary Care Study Teams OBOI
"Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study.".
Am. J. Epidemiol.. 195(4): 1108 - 1119. 2026. [doi:10.1093/aje/kwaf254]
Antunes, L, Nunes, B, Núñez, O, Martínez-Baz, I, Dockx, Y, Borg, ML, Oroszi, B, Duffy, R, Dürwald, R, Kuliese, M, Machado, A, Petrovic, G, Lazar, M, Guiomar, R, Río, VA, Castilla, J, Magerman, K, Dziugyte, A, Túri, G, Fitzgerald, M, Hackmann, C, Jancoriene, L, Gomez, V, Makaric, ZL, Popovici, O, Rojas-Castro, M, Rose, AMC
"Modelling approaches for estimating vaccine effectiveness of consecutive SARS-CoV-2 variant sublineages in the absence of study-specific genetic sequencing data, VEBIS hospital network, Europe, 2023/24".
PLoS One. 21(3): e0343988. 2026. [doi:10.1371/journal.pone.0343988]
Núñez, O, Juaneda, J, Martinez-Marcos, M, Platón, EM, Wagner, ER, Santiago-Pérez, MI, Rio, VA, Moreno, MZ, Ibáñez, AF, Suarez, GP, Ortiz, GL, Egüés, N, Sáenz, BB, Franco, MDC, Cobo, SC, Padilla, MD, Castrillejo, D, Santiyán, AM, Basile, L, López, MARD, Curbelo, DS, Pérez-Martínez, O, Recio, MJR, Gómez, LD, Vigil, MDA, Diaz, MM, Sancho, R, Castilla, J, Pérez, ACI, Rebollo, NB, Piorno, LS, Berrios, NL, Lamas, J, Olmedo, C, Monge, S, Pastor-Barriuso, R
"Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025".
Eurosurveillance. 31(9): 2500593. 2026. [doi:10.2807/1560-7917.ES.2026.31.9.2500593]
Pardos-Plaza, J, Martínez-Baz, I, Toledo, D, Miret, C, Parrón, I, Ferras, J, Alsedà, M, Carol, M, Zayas, M, Sanz, I, García-Cenoz, M, Caylà, JA, Castilla, J, Domínguez, A, Godoy, P
"Impact of Smoking on Household SARS-CoV-2 Transmission".
Healthcare. 14(4): 540. 2026. [doi:10.3390/healthcare14040540]
Pham, TT, Nimptsch, K, Aleksandrova, K, Jenab, M, Fedirko, V, Olsen, A, Tjonneland, A, Cadeau, C, Severi, G, Schulze, MB, Fortner, RT, Katzke, V, Agnoli, C, Sacerdote, C, Tumino, R, Signoriello, S, Trobajo-Sanmartín, C, Gómez, J, Chirlaque, M, Sánchez, M, Crous-Bou, M, May, A, Heath, A, Aune, D, Weiderpass, E, Pischon, T
"Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study".
Int. J. Cancer. 158(3): 546 - 559. 2026. [doi:10.1002/ijc.70090]
Michaud, DS, Platz, EA, Garrett, WS, Waterboer, T, Kaaks, R, Pasanisi, F, Abilleira, E, Pala, V, Milani, L, Castilla, J, Palacios, DR, Tumino, R, Masala, G, Farràs, M, Sánchez, MJ, Papier, K, Severi, G, Tsilidis, KK, Jenab, M, Butt, J, Hughes, DJ
"Antibody Responses to 11 Fusobacterium Proteins and Colorectal Cancer-Specific and Overall Survival in the EPIC Cohort".
Cancer Epidemiol. Biomarkers Prev.. 35(1): 88 - 94. 2026. [doi:10.1158/1055-9965.EPI-25-1084]
García, IA, Beguiristain, I, Fernández-Huerta, M, Castilla, J, Bordonabe, MEP
"Invasive pneumococcal disease before, during and after the SARS-CoV-2 pandemic".
Enferm. Infec. Microbiol. Clin.. 44(1): 503033. 2026. [doi:10.1016/j.eimc.2025.503033]
|